Remove 2024 Remove Compliance Remove Pharmaceutical
article thumbnail

Emerging Technologies in Pharmaceutical Manufacturing: Modular and Automated Platforms

Frost & Sullivan Manufacturing

In the ever-evolving landscape of pharmaceutical manufacturing, modular and automated platforms are spearheading a transformative shift, particularly in the realm of non-biologics. Apertus Pharmaceuticals and the API Innovation Center advanced lomustine production with continuous flow biomanufacturing solutions.

article thumbnail

Software Streamlines Pharmaceutical Development

Gary Mintchell

Global automation technology and software leader Emerson on April 16, 2024 introduced DeltaV Workflow Management, a next-generation software designed for life sciences companies in early-stage development. The post Software Streamlines Pharmaceutical Development appeared first on The Manufacturing Connection.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

LSL Pharma Group Inc. announces the acquisition of Dermolab Pharma Ltd.

Canadian Manufacturing

a Canadian integrated pharmaceutical Corporation, announces the acquisition of Dermolab Pharma Ltd., The closing of the transaction occurred after markets had closed on December 17, 2024. BOUCHERVILLE — LSL PHARMA GROUP INC., Steri-Med Pharma Inc. and Virage Sant Inc. Steri-Med Pharma Inc. and Virage Sant Inc.

article thumbnail

Environmental Compliance and Pharmaceutical Quality Standards Pave the Way for Transformational Growth in Chromatography

Frost & Sullivan Manufacturing

SAN ANTONIO, 12 th August 2024 – Chromatography instruments and modular test equipment are revolutionising scientific analysis and industrial testing. By enabling precise separation and analysis of complex mixtures, chromatography plays a crucial role in ensuring pharmaceutical purity, food safety, and environmental compliance.

article thumbnail

Building an Integrated, End-to-End R&D and Manufacturing Service Platform with Innovative R&D and High-end Preparation Technologies

Frost & Sullivan Manufacturing

Aligning with Industry Trends: Healthnice Advances Step by Step Amid the global pharmaceutical industry’s evolution, high-end preparations have become a mainstream trend in drug development. Therefore, for pharmaceutical companies, high-end preparations represent a high-value, cost-effective strategy for differentiation.

article thumbnail

Growth Opportunities Transforming the Coatings Industry: From Advanced Fire Protection to Sustainable Packaging

Frost & Sullivan Manufacturing

The Coatings Ecosystem: Innovations Across Industries Sustainable Packaging Coatings: As countries combat carbon emissions, sustainable packaging coatings are becoming essential to reduce landfill waste, especially for industries like food, pharmaceuticals, and personal care.

article thumbnail

Moderna appoints manufacturing site head for Melbourne mRNA vaccine facility

Manufacturer's Monthly

today announced the appointment of Emma Harrington as the inaugural manufacturing site head for the company’s new mRNA vaccine manufacturing site in the Monash Technology Precinct in Melbourne, Australia, effective February 2024. Moderna, Inc.